RNWL
INTERNATIONAL REGISTRATION RENEWED
07/11/2025
Back to search
Official data from USPTO
LYMPHOFLUIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/12/2025
Trademark type
Word
Nice classes
3
Filing date
10/26/2015
Registration date
06/14/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2022
Last transaction
07/12/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
LAM, HAI-LY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Paul Scerri SA
Representatives
Meyerlustenberger Lachenal
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Soapsperfumeryessential oilscosmeticshair lotions; massage oilsdentifrices
Publications
History of USPTO decisions and trademark events.
26 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/13/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2024
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/09/2023
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/19/2023
INPC
INVALIDATION PROCESSED
09/19/2023
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/30/2023
C71T
CANCELLED SECTION 71
12/30/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/06/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/17/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/01/2017
GPNX
NOTIFICATION PROCESSED BY IB
02/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/15/2016
FIMP
FINAL DISPOSITION PROCESSED
07/15/2016
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
07/14/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2016
PUBO
PUBLISHED FOR OPPOSITION
03/29/2016
GPNX
NOTIFICATION PROCESSED BY IB
03/26/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/09/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/09/2016
NPUB
NOTICE OF PUBLICATION
03/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2016
DOCK
ASSIGNED TO EXAMINER
02/18/2016
MAFR
APPLICATION FILING RECEIPT MAILED
01/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2016
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOFLUIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.